2Mo·

United Health

$UNH (+1,57 %)
$CNC (+5,19 %)
$US60855R1005 (+3,35 %)
$ELV (+3,72 %)
$CVS (+0,02 %)

How the loss of $CNC (+5,19 %) and $US60855R1005 (+3,35 %) shows, Medicaid is charity care because you lose money when you care for the sickest and poorest population. To make a profit, you want as few Medicaid patients as possible.

$UNH (+1,57 %) is in a better position ✌️

BamBamInvest

@BamBamInvest

2Mo·

Centene Q2'25 result highlights

$CNC (+5,19 %)

Next sale in the health insurance sector ?

🔹 Revenue: USD 48.74 billion (estimated USD 44.24 billion) ✅

🔹 Adjusted earnings per share: ( USD 0.16) (estimated USD 0.23) ❌

🔹 Health insurance ratio: 93.0% (estimated 91.6%) ❌ ; increase of +5.4 percentage points compared to the previous year

🔹 Total income from premiums and services: USD 42.47 billion; increase of 18% compared to the previous year

🔹 Selling and administrative expenses ratio: 7.1 %

Segment revenue:

🔹 Medicaid: USD 21.72 billion; increase of 7% compared to the previous year

Commercial: USD 10.07 billion; increase of 18% compared to the previous year

🔹 Medicare: USD 9.45 billion; increase of 58% compared to the previous year

🔹 Other: USD 1.22 billion; increase of 1% compared to the previous year

Other metrics

🔹 Cash flow from operating activities: USD 1.79 billion

🔹 Payability days for claims: 47 days

CEO comment:

➡️ "We are disappointed with our second quarter results, but have a clear understanding of the trends that impacted our performance and are working diligently and with focus to restore our earnings performance." - Sarah M. London

➡️ "Despite the changing landscape, we believe the staying power of Medicaid, Medicare and the Individual Marketplace is stronger than ever." - Sarah M. London

$UNH (+1,57 %)
$US60855R1005 (+3,35 %)
$CVS (+0,02 %)
$CI (+4,52 %)
$XDWH (+0,93 %)

14 Commentaires

HyperX@WallStreet007

2Mo

A big fish must have just made a purchase at $CNC

•

Christian@WarrenBuffettsVater

2Mo

@GGHyperX I read through the article here -15%, then did my own research, came back and +-0%. Will be like this

••

BamBamInvest@BamBamInvest

2Mo

@GGHyperX everything is just a bit exaggerated ✌️

•

Pawfolio@Pawfolio

2Mo

I think we're definitely getting into oversold territory.
There may be one last bloodbath triggered by UNH. Unfortunately, I got into UNH too early.

•

BamBamInvest@BamBamInvest

2Mo

@Pawfolio see if there is one last downward blow, but I believe that we have already priced in a lot of negativity here, also for $UNH earnings

•

Michael@Neverloosemoney

2Mo

Entered at 19.80 euros today

•

ThemenmitKopf@topicswithhead

2Mo

How do you see the PBM business? Is it priced in that it might be discontinued or not?

•

BamBamInvest@BamBamInvest

2Mo

@topicswithhead I think a lot has already been priced in here, but only the future will show what the real impact will be.

••

ThemenmitKopf@topicswithhead

2Mo

@BamBamInvest I'm out at 275 for now, but my fingers are itching. Would like to get in but the company already has a lot of pressure

•

BamBamInvest@BamBamInvest

2Mo

@topicswithhead yes, but you can see the reaction, a lot is already priced in, only worse figures would be fatal, but that won't happen because they will perform in their main sales business and the Medicare/Medicaid share is relatively low. I am positive and hope for an early result of the investigation.

••

ThemenmitKopf@topicswithhead

2Mo

@BamBamInvest well, regardless of whether it is priced in or not, if the PBM business disappears, the share price will still fall. The same applies to Medicare. If growth there is lower than 5, that would also be bad. I can see the low valuation, but the main areas are simply under a lot of pressure. Without PBM, the practices are also much less worthwhile. The positive things you always emphasize can of course backfire hard. Difficult in any case. I actually want to get in before the figures

•

ThemenmitKopf@topicswithhead

2Mo

@topicswithhead I have no problem going through bad times, as you can see in my portfolio, but the negative news makes me very uneasy. It's just news that goes to the fundamentals of the business.

••

BamBamInvest@BamBamInvest

2Mo

@topicswithhead Yes, there are a lot of uncertain variables, but in my opinion it's not as bad as expected at first. Similar to $MC or $CNC today. The last few days have been really exaggerated, it is possible that further pressure will come here, but I think a rebound is the order of the day for now. I also think that some funds and hedge funds will buy in.

•

BamBamInvest@BamBamInvest

2Mo

@topicswithhead yes, but some of this is old news, you really get the feeling that everything is being rehashed twice and you really want to piss on someone's leg. Look how big the company is, don't you think there would be a lot more accusations, there are always unhappy customers or patients or common practices. Let them make an example, find something, pay a fine and that's it. With such a size and volume, there are always inconsistencies, but then you would have to pillory many companies.
I'm really relaxed about it. Even the new CEO is liable if he knowingly takes over a company with dubious practices. To be honest, I wouldn't worry so much about that, the prospects are the difficult part in my opinion, but here too they could perhaps even swallow up one or two competitors or profit from them. I also see a lot of opportunities here 😁

••